Yeah, it’s the same old tune: management wins, shareholders lose.
Take a hard look at the companies Paul Hopper (IMU’s Executive Chair and Director) is involved with. Here’s how they’ve performed for shareholders:
All down 90%+ since 2021.
But guess what? Paul and the crew are still cashing in. He’s pocketing millions from these companies while lining up the so-called "performance" (ironic) rights for himself. Here’s what he’s pulling out of IMU every year:
Some eye watering salaries in there, including just 4 doctors taking over $2 mill and they get paid these great salaries for years, whilst shareholders lose everything, luckily for IMU doctors they got a few more years of great salaries before we are out of money.
It would be great if the Drs involved were more incentivised with the share price doing well, a lot of them dont really have their own skin in the game apart from the free performnce rights , and can just jump over to another biotech once money dries up or they hey just stay just stay in doing cap raise after cap raise, share holders getting diluted into oblivion , and they can pay themselves for decades.
The worst part? When the cash dries up, the doctors and execs move on to the next biotech, leaving retail investors stuck with the wreckage.
This is exactly why shareholders need to demand accountability. Its hard now though with the model already in place. These execs shouldn’t be coasting on guaranteed million-dollar paychecks while the rest of us watch our investments bleed out. Tie their incentives to the share price—make them feel the pain or the gain just like shareholders do.
Without incentivised for the shareprice to do well, It’s actually better for these doctors and execs to keep the company limping along rather than taking a real risk. If they take a big swing and fail, the gravy train ends. But if they drag their feet, string shareholders along with endless "progress updates," and avoid any decisive moves, they can milk the company for millions over years.
Why push for a breakthrough when slow-walking everything ensures fat salaries, performance rights, and a cozy job for the foreseeable future? It’s a broken system that punishes shareholders and rewards complacency.
Unless something changes—we’re stuck funding their luxury lifestyles while they avoid doing the very thing they’re paid to do: deliver results.
IMU Price at posting:
3.8¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)